A phase 1 study of LY007, a novel anti-CD20 CAR-T cell therapy in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

被引：0
|
作者：
Yan, Zixun
Sheng, Lingshuang
Wang, Li
Wu, Wen
Zhang, Yilun
Shen, Rong
Cao, Weiguo
Li, Lei
Chen, Sheng
Jiang, Xufeng
Yi, Hongmei
Song, Qi
Wang, Li
Cheng, Shu
Xu, Peng-Peng
Li, Jianyong
Zhao, Weili
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[2] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7027
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cytopenia after CAR-T cell therapy: Analysis of 63 patients with relapsed and refractory B-cell non-Hodgkin lymphoma
    Qiu, Tingting
    Hu, Luan
    Zhang, Yongtian
    Wang, Ying
    Ma, Sha
    Li, Depeng
    Li, Zhenyu
    Xu, Kailin
    ONCOLOGY LETTERS, 2023, 26 (02)
  • [2] A CD19/CD20-Directed Bispecific CAR-T Cell Therapy in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)
    Larson, Sarah M.
    Chen, Yvonne Y.
    Johnston, Jim
    Roy, Sylvain
    Patel, Pinakin
    Benjamin, Jonathan E.
    BLOOD, 2023, 142
  • [3] Safety and efficacy of a novel anti-CD20 chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory (r/r) B-cell non-Hodgkin lymphoma (B-NHL) patients after failing CD19 CAR-T therapy.
    Liang, Aibin
    Ye, Shiguang
    Li, Ping
    Huang, Jiaqi
    Zhu, Shigui
    Yao, Xin
    Zhou, Lili
    Xu, Yangyang
    Zhu, Judy
    Zheng, Chengxiao
    Chen, Shiyi
    Lan, Liping
    Lv, Xiaoteng
    Wei, Yutian
    Humphries, Michael
    Yao, Yihong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma
    Yuen, Sam
    Phillips, Tycel J.
    Bannerji, Rajat
    Marlton, Paula
    Gritti, Giuseppe
    Seymour, John F.
    Johnston, Anna
    Arthur, Christopher
    Dodero, Anna
    Sharma, Sunil
    Hirata, Jamie
    Musick, Lisa
    Flowers, Christopher R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1281 - 1289
  • [5] Hypoxia-Specific Imaging Before CAR-T Therapy in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
    Pandita, Divita
    Banerjee, Rahul
    Wang, Victoria
    Huang, Chiung-Yu
    Leonard, Michelle
    Larue, Siobhan
    Ahmadi, Michael
    Kaplan, Lawrence
    Ai, Weiyun
    Fakhri, Bita
    Spinner, Michael
    Seshadri, Madhav
    Pampaloni, Miguel
    Andreadis, Charalambos
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S429 - S430
  • [6] Factors Associated With Duration of Response After CD-Specific CAR-T Cell Therapy for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 13 - 14
  • [7] Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
    Ramos, Carlos A.
    Grover, Natalie S.
    Beaven, Anne W.
    Lulla, Premal D.
    Wu, Meng-Fen
    Ivanova, Anastasia
    Wang, Tao
    Shea, Thomas C.
    Rooney, Cliona M.
    Dittus, Christopher
    Park, Steven I.
    Gee, Adrian P.
    Eldridge, Paul W.
    McKay, Kathryn L.
    Mehta, Birju
    Cheng, Catherine J.
    Buchanan, Faith B.
    Grilley, Bambi J.
    Morrison, Kaitlin
    Brenner, Malcolm K.
    Serody, Jonathan S.
    Dotti, Gianpietro
    Heslop, Helen E.
    Savoldo, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3794 - +
  • [8] C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical study
    Li, Ping
    Liu, Wei
    Zhou, Lili
    Ye, Shiguang
    Zhu, Dan
    Huang, Jiaqi
    Li, Jing
    Zheng, Chengxiao
    Zhu, Shigui
    Yao, Xin
    Zhu, Kevin
    Yao, Yihong
    Qiu, Lugui
    Liang, Aibin
    Zou, Dehui
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) : 2306 - 2312
  • [9] Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
    Cordeiro, Ana Costa
    Durisek, George
    Batista, Marjorie Vieira
    Schmidt, Jayr
    de Lima, Marcos
    Bezerra, Evandro
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] Follow-up on phase 1 study of AT101, a novel anti-CD19 chimeric antigen receptor cell therapy (CAR-T) in patients with relapsed or refractory (r/r) b-cell non-Hodgkin lymphoma
    Kim, Ki Hyun
    Yoon, Dok Hyun
    Jo, Jae-Cheol
    Jeong, Seong Hyun
    Oh, Sung Yong
    Cho, Hyungwoo
    Choi, Yoon Seok
    Kim, Sung-Hyun
    Lee, Ji Hyun
    Cui, LeiGuang
    Lee, Tae-Bum
    Hwang, In-Sik
    Lee, Young-Ha
    Lee, Yong-Jun
    Lee, Yoon
    Kim, Jong-Hoon
    Lee, Jong-Seo
    Chung, Junho
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345